Overhauling Compliance and GMPs

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-04-02-2003
Volume 27
Issue 4

FDA's newly launched risk-based approach to GMP regulation spurs signficant changes in the agency's approach to inspection processes, postapproval changes, and 21 CFR Part 11 enforcement.

Recent Videos
CPHI Milan 2024: Compliance and Automation in Aseptic Processing